William Mann, PhD, MBA, is a biopharma executive with extensive experience in R&D, commercialization, and innovation leadership. They served as President & CEO of Helsinn Therapeutics from 2009 to 2018, transforming the company into a profitable entity. Mann has held various influential roles, including Director of Global Business Development and Licensing at Novartis and President and COO at NeuBase Therapeutics, Inc. Currently, they are a member of the Board of Directors at ARDAN PHARMA and a Senior Technology Manager at TechLink. Mann is also pursuing a Postdoctoral Fellowship in Human Genetics at The Rockefeller University, a PhD in Biochemistry at the University of Aberdeen, and an MBA at Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices